Table 1.
HER2 Targeted Peptides.
| Peptide | Labeling Strategy | Kd (nM) | Reference |
|---|---|---|---|
| KCCYSL | 111In-DOTA-GSG | 295 ± 56 | 16 |
| MEGPSKCCYSLALASH | 111In-DOTA | 236 ± 83 | 18 |
| GTKSKCCYSLRRSS | 111In-DOTA | 289 ± 13 | 18 |
| LTVSPWY | N/A | N/A | 21 |
| CGGGLTVSPWY | 99mTc | 4.3 ± 0.8 | 22 |
| CSSSLTVSPWY | 99mTc | 33.9 ± 9.7 | 22 |
| FCGDFYACYMDV | 111In-DTPA-peptide-PEG | 300 | 26 |
| H6F | 99mTc-HYNIC | N/A | 28 |
| A9 | 111In-DTPA | 4.9 and 103 | 29 |
| CDTFPYLGWWNPNEYRY | Cy5.5 | 18.6 | 30 |
| CKTIYYLGYYNPNEYRY | Cy5.5 | 81.2 | 30 |
| GGCAKIFGSLAFLKCCYSL | 99mTc | 50.0 ± 14 | 31 |
| YHWYGYTPQNVI | 99mTc-tricine-HYNIC-SSS | 73 ± 14 | 33 |